Supporting evidence

• LedgerMixed quarter based on: Focus on corporate governance rather than financial performance · Potential for future equity issuance and capital raise · Lack of Q2 2026 financial metrics.
• EventCorporate Event Announced
• EventPotential Capital Raise

• EventLikely related to corporate governance and potential financial actions (allotment of equity securities).
• EventA capital raise intended to provide funding for the company's operations and development programs.
• EventRoutine re-appointment of auditor, indicating ongoing financial oversight.
• InitiativeResolutions 8 and 10, which were key to this initiative, failed to pass at the re-scheduled AGM, meaning the initiative has not been approved as proposed.
• InitiativeADR ratio change announced, but effectiveness is not assured.
• InitiativeSuccessfully in-licensed MTX240 from Otsuka, strategically aligning with existing pipeline including eRapa.
• InitiativeMandatory change effective April 6, 2026. No assurance of effectiveness.
• EventDilution risk from equity issuance
• EventUncertainty regarding use of proceeds from potential capital raise